TrialAIDS research and human retroviruses2022

A Randomized, Double Blind, Placebo-Controlled, Phase 1 Safety, and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults (MTN-026).

Ross D Cranston et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.